Fulfilling the Mandate of the US Food and Drug Administration’s Accelerated Approval Pathway

Abstract: This Viewpoint discusses the US Food and Drug Administration’s accelerated approval pathway and proposes the need for reforms as well as the timely completion of postapproval trials.